Guest Contributor

Importance of biotech to federal innovation strategy evident in latest StatsCan data

Guest Contributor
May 28, 2001

Federal biotechnology outlays are continuing on a rapid upward trajectory with $392 million in R&D and related scientific expenditures in FY99-00, according to the most recent data from Statistics Canada.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News

Biotech R&D spending slowed in 1998 but StatsCan survey excludes smaller firms

WestLink launches pilot internship program for tech transfer and commercialization skills

Canada’s colleges and institutes ready to play greater role in applied research

iFire Technology moving quickly to enter consumer market for flat panel displays






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.